Kisunla (donanemab-azbt) is a prescription drug used to treat Alzheimer’s disease. The drug is given as an intravenous (IV) infusion by a healthcare professional. You’ll typically receive a dose of Kisunla once every 4 weeks.
Kisunla treatment is usually started in people who have mild Alzheimer’s disease symptoms.
The active ingredient in Kisunla is donanemab-azbt. Kisunla belongs to a group of drugs called amyloid beta-directed antibodies.
This article describes the dosages of Kisunla, as well as its strength and how to take it. To learn more about Kisunla, see this in-depth article.
Note: As a person’s condition progresses, they may need help reading or understanding certain information about their treatment plan. This article contains details that may help caregivers learn more about key aspects of Kisunla.
The following table highlights the basics of Kisunla’s dosage. All doses are listed in milligrams (mg).
| Kisunla form | Kisunla strength | Starting dosage | Maximum dosage |
| liquid solution given as an intravenous (IV) infusion | 350 mg in 20 milliliters (mL) of solution (17.5 mg/mL) | 700 mg given every 4 weeks | 1,400 mg given every 4 weeks |
Keep reading for more details about Kisunla’s dosage.
What is Kisunla’s form?
Kisunla comes as a liquid solution that’s given as an IV infusion (an injection into your vein over a period of time). Your doctor or another healthcare professional will give you the infusions.
What strength does Kisunla come in?
Kisunla comes in one strength of 350 mg in 20 mL of solution (17.5 mg/mL).
What are the usual dosages of Kisunla?
Your doctor will likely start you on a low dosage and adjust it over time to reach the right amount for you. They’ll ultimately prescribe the smallest dosage that provides the desired effect.
The following information describes dosages that are commonly used or recommended. But your doctor will determine the best dosage to fit your needs. In some cases, doctors may adjust your dosage from those shown below.
Dosage for Alzheimer’s disease
The typical starting dosage for adults with Alzheimer’s disease is 700 mg of Kisunla, given every 4 weeks for the first three doses. After that, your doctor will likely increase your dose to 1,400 mg given every 4 weeks.
Kisunla comes as a liquid solution that’s given as an IV infusion by your doctor or another healthcare professional. You’ll receive doses at a clinic, your doctor’s office, or another healthcare facility.
Kisunla infusions typically last around 30 minutes. After you receive each infusion, your doctor may ask you to stay at the facility for at least 30 minutes. This is so they can monitor you for possible side effects caused by the infusion, such as an allergic reaction.
Is Kisunla used long term?
Yes, Kisunla is typically used as a long-term treatment. If you and your doctor determine that it’s safe and effective for your condition, you’ll likely use it long term.
If you have questions about how long your Kisunla treatment may last, talk with your doctor.
Disclaimer: Healthline has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.